Ebru Ozdemir

Alternate-Day Versus Consecutive-Day Anti-T Lymphocyte Globulin Induction in First Living-Donor Kidney Transplant Recipients at Low Immunological Risk: A Retrospective Cohort Study

Background/Objectives: Anti-T lymphocyte globulin (ATLG) is widely used as induction therapy in kidney transplantation; however, the clinical impact of the interval between individual ATLG doses remains poorly defined. We compared alternate-day and consecutive-day ATLG administra...